Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Apoptosis | R-HSA-109581 | map04210 | repaglinide | 65981 | drug-path |
| Asthma | R-HSA-444620 | map05310 | repaglinide | 65981 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | repaglinide | 65981 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | repaglinide | 65981 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | repaglinide | 65981 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | repaglinide | 65981 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | repaglinide | 65981 | drug-path |
| Natural killer cell mediated cytotoxicity | R-HSA-5218921 | map04650 | PF-00562151-00 | None | drug-path |
| Alzheimer's disease | R-HSA-1643685 | 0 | PF-00562151-00 | None | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | PF-00562151-00 | None | drug-path |
| Taste transduction | R-HSA-162582 | map04742 | PF-00562151-00 | None | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | PF-00562151-00 | None | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | PF-00562151-00 | None | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | PF-00562151-00 | None | drug-path |
| Cardiac muscle contraction | R-HSA-397014 | map04260 | PF-00562151-00 | None | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | PF-00562151-00 | None | drug-path |
| Ribosome | R-HSA-5368277 | map03010 | PF-00562151-00 | None | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | PF-00562151-00 | None | drug-path |
| ECM-receptor interaction | R-HSA-373711 | map04512 | PF-00562151-00 | None | drug-path |
| Jak-STAT signaling pathway | R-HSA-168638 | map04630 | PF-00562151-00 | None | drug-path |